Oppenheimer Holdings Stock News

Broadcom (NASDAQ:AVGO) had its price objective boosted by equities researchers at Oppenheimer from $575.00 to $650.00 in a research note issued on Friday, Benzinga reports. The firm presently has an outperform rating on the semiconductor manufacturers stock. Oppenheimers price objective would suggest a potential upside of 17.66% from the companys previous close. Other equities research []

Investment analysts at Oppenheimer initiated coverage on shares of ESS Tech (NYSE:GWH) in a report released on Thursday, The Fly reports. The firm set an outperform rating on the stock. GWH has been the subject of several other reports. Loop Capital assumed coverage on shares of ESS Tech in a research report on Thursday, October []

Utz Brands, Inc. (NYSE:UTZ)s stock price reached a new 52-week low on Monday . The company traded as low as $15.00 and last traded at $15.06, with a volume of 54131 shares changing hands. The stock had previously closed at $15.37. A number of analysts have weighed in on the stock. Oppenheimer decreased their target []

Universal Display Co. (NASDAQ:OLED) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $142.54 and last traded at $142.83, with a volume of 2580 shares trading hands. The stock had previously closed at $144.44. Several equities analysts recently issued reports on OLED shares. Oppenheimer decreased their []

DICKS Sporting Goods, Inc. (NYSE:DKS) Investment analysts at Oppenheimer raised their FY2022 earnings per share (EPS) estimates for shares of DICKS Sporting Goods in a research report issued on Wednesday, November 24th. Oppenheimer analyst B. Nagel now anticipates that the sporting goods retailer will earn $14.40 per share for the year, up from their []

Equities researchers at Oppenheimer started coverage on shares of Caribou Biosciences (NASDAQ:CRBU) in a research report issued on Tuesday, The Fly reports. The brokerage set an outperform rating on the stock. CRBU has been the topic of a number of other reports. SVB Leerink initiated coverage on Caribou Biosciences in a research note on Tuesday, []

TheStreet lowered shares of Conformis (NASDAQ:CFMS) from a c rating to a d+ rating in a report published on Friday, TheStreetRatingsTable reports. Several other analysts have also commented on the stock. Zacks Investment Research raised shares of Conformis from a sell rating to a hold rating in a research report on Tuesday, November 16th. Oppenheimer []

Investment analysts at Wedbush assumed coverage on shares of Consensus Cloud Solutions (NASDAQ:CCSI) in a research report issued on Tuesday, The Fly reports. The firm set an outperform rating on the stock. Separately, Oppenheimer assumed coverage on shares of Consensus Cloud Solutions in a research report on Thursday, November 4th. They issued an outperform rating []

CHICAGO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. ("Chicago Atlantic"), a commercial real estate finance company that intends to elect and qualify to be taxed as a REIT under Section 856 of the Internal Revenue Code of 1986, today announced the filing of a registration statement on Form S-11 related to an initial public offering of 6,250,000 shares of its common stock. The price range for this offering is currently $16.00 to $18.00 per share of common stock. Chicago Atlantic has applied to have its common stock approved for listing on the NASDAQ Global Market under the symbol "REFI." In connection with this offering, Chicago Atlantic is expected to grant the underwriters a 30-day option to purchase up to an additional 937,500 shares of its common stock. The completion of the proposed offering depends upon several factors, including market and other conditions. Chicago Atlantic is managed by Chicago Atlantic REIT Manager, LLC. Chicago Atlantic''s primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time primarily through consistent current income dividends and other distributions and secondarily through capital appreciation.

Deere & Company (NYSE:DE) Equities researchers at Oppenheimer issued their Q1 2022 earnings estimates for Deere & Company in a report released on Friday, November 26th. Oppenheimer analyst K. Owen expects that the industrial products company will earn $3.48 per share for the quarter. Oppenheimer also issued estimates for Deere & Companys Q2 2022 [] The post Deere & Company (NYSE:DE) Forecasted to Post Q1 2022 Earnings of $3.48 Per Share appeared first on ETF Daily News .

Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) Oppenheimer lowered their FY2021 EPS estimates for shares of Clarus Therapeutics in a note issued to investors on Wednesday, November 24th. Oppenheimer analyst L. Gershell now forecasts that the company will post earnings per share of ($8.29) for the year, down from their previous forecast of ($6.82). Oppenheimer has []

Oppenheimer (NYSE: OPY) is one of 53 public companies in the Security brokers & dealers industry, but how does it compare to its rivals? We will compare Oppenheimer to similar businesses based on the strength of its analyst recommendations, risk, dividends, institutional ownership, profitability, valuation and earnings. Insider and Institutional Ownership 44.3% of Oppenheimer shares []

Oppenheimer (NYSE: OPY) is one of 53 public companies in the Security brokers & dealers industry, but how does it weigh in compared to its competitors? We will compare Oppenheimer to related companies based on the strength of its earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Analyst Recommendations This is a breakdown []

Oppenheimer (NYSE: OPY) is one of 53 publicly-traded companies in the Security brokers & dealers industry, but how does it contrast to its peers? We will compare Oppenheimer to similar businesses based on the strength of its dividends, institutional ownership, profitability, analyst recommendations, earnings, risk and valuation. Profitability This table compares Oppenheimer and its peers []